Pivagabine is an antiepileptic drug investigated for the treatment of epilepsy. It acts by inhibiting the breakdown of gamma-aminobutyric acid (GABA), thereby increasing inhibitory neurotransmission in the brain to help control seizures. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include N-trimethylacetyl GABA and Pivagabina. Its PubChem CID is 68888.
Pivagabine
| CAS No | 69542-93-4 |
|---|---|
| Molecular Formula | C9H17NO3 |
| Molecular Weight | 187.24 g/mol |
| Synonyms | 4-(2,2-dimethylpropanoylamino)butanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pivagabine is an antiepileptic drug investigated for the treatment of epilepsy. It acts by inhibiting the breakdown of gamma-aminobutyric acid (GABA), thereby increasing inhibitory neurotransmission in the brain to help control seizures.
The listed CAS number is 69542-93-4.
The listed molecular formula is C9H17NO3.
The listed molecular weight is 187.24 g/mol.
4-(2,2-dimethylpropanoylamino)butanoic acid.
The source lists N-trimethylacetyl GABA and Pivagabina.